Table 2.
Analysis of differences in clinical factors between the two groups
| Analyte | Remission group (n = 49) | Non-remission group (n = 11) | OR (95% CI) | P |
|---|---|---|---|---|
| Vit-D | 20.92 ± 6.15 | 16.43 ± 5.7 | 0.861 (0.749–0.991) | 0.036 |
| CRP | 12 (5–46) | 79.4 (29.5–106.9) | 1.028 (1.01–1.047) | 0.003 |
| ESR | 17 (9–29.5) | 42 (27–63) | 1.053 (1.017–1.089) | 0.003 |
| Hs-CRP | 21.71 (2.61–54.39) | 66.55 (20.15–95.85) | 1.023 (1.004–1.041) | 0.016 |
| WBC | 6.61 (5.23–8.77) | 8.02 (6.33–8.51) | 1.187 (0.903–1.56) | 0.22 |
| RBC | 4.63 ± 0.6 | 4.9 ± 0.93 | 0.268 (0.091–0.785) | 0.016 |
| Hb | 121.52 ± 22.1 | 98.73 ± 23.59 | 0.956 (0.923–0.99) | 0.011 |
| MCV | 82.7 (76.45–89.55) | 79.9 (72.7–82.7) | 0.986 (0.933–1.042) | 0.614 |
| PLT | 349.77 ± 123.4 | 394.36 ± 107.79 | 1.003 (0.998–1.008) | 0.272 |
| PA | 170 (150–248.5) | 134 (102–152) | 0.974 (0.954–0.994) | 0.011 |
| ALB | 41.7 (37.65–45.15) | 35.7 (33.7–41) | 0.933 (0.857–1.016) | 0.11 |
| AST | 14.6 (11.4–20.55) | 12 (10.2–13.4) | 0.93 (0.828–1.045) | 0.222 |
| ALT | 11.1 (7.75–21.45) | 8.1 (4.7–8.7) | 0.923 (0.831–1.025) | 0.136 |
| ALP | 72.6 (60.45–93.55) | 75.3 (70–83.4) | 1.004 (0.98–1.03) | 0.727 |
| GGT | 20.3 (13.7–35) | 22.2 (17.6–33) | 1.006 (0.97–1.044) | 0.755 |
| TBil | 9 (7.3–13.25) | 6.9 (5.9–11.4) | 0.848 (0.677–1.063) | 0.153 |
| DBil | 2.1 (1.45–2.7) | 1.6 (1.1–2.8) | 0.612 (0.273–1.374) | 0.235 |
| TBA | 1.7 (1.08–2.6) | 1.25 (0.58–3.15) | 1.054 (0.737–1.507) | 0.773 |
| BUN | 4.24 ± 1.48 | 3.13 ± 0.92 | 0.486 (0.254–0.929) | 0.029 |
| Cr | 68.93 ± 15.1 | 60.34 ± 12.67 | 0.959 (0.913–1.007) | 0.09 |
| Uric Acid | 332.39 ± 95.28 | 307.3 ± 71.71 | 0.997 (0.989–1.004) | 0.409 |
| Cys-C | 0.78 (0.69–0.94) | 0.83 (0.7–0.86) | 0.972 (0.335–2.816) | 0.958 |
| Blood Ca | 2.27 ± 0.12 | 2.18 ± 0.13 | 0.003 (0–0.707) | 0.037 |
| Blood Mg | 0.85 ± 0.07 | 0.85 ± 0.11 | 0.994 (0–5327.857) | 0.999 |
| Fe | 7.8 (4.1–13.4) | 7.86 (6.38–10.38) | 0.981 (0.798–1.205) | 0.852 |
| Blood K | 4.08 (3.92–4.2) | 4.02 (3.56–4.27) | 0.169 (0.022–1.313) | 0.089 |
| Blood Na | 138.02 ± 2.18 | 138.02 ± 1.86 | 1 (0.732–1.367) | 0.998 |
| Blood P | 1.19 ± 0.23 | 1.22 ± 0.25 | 1.527 (0.076–30.586) | 0.782 |
| Blood glucose | 4.36 (3.96–4.65) | 4.35 (4.07–5.01) | 1.619 (0.695–3.773) | 0.264 |
| Serum Ferritin | 75.33 (42.78–358.56) | 151.78 (12.83–262.36) | 0.999 (0.995–1.003) | 0.612 |
| Folic acid | 6 (3–8) | 4.67 (3–5.5) | 0.841 (0.645–1.097) | 0.202 |
| VB12 | 443 (339–619) | 477 (393–572) | 1 (0.996–1.004) | 0.999 |
| EPO | 14.85 (11.5–22.2) | 16.2 (13.75–106.55) | 1.002 (0.999–1.006) | 0.177 |
| TC | 3.33 (2.82–4.17) | 0.92 (0.79–1.12) | 0.613 (0.233–1.614) | 0.322 |
| TG | 0.89 (0.68–1.12) | 0.92 (0.79–1.12) | 0.751 (0.254–2.22) | 0.604 |
| FBG | 4.2 (3.49–4.32) | 4.6 (3.87–5.15) | 1.723 (0.86–3.452) | 0.125 |
| ANA | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0.999 |
| IFX-TC | 4 (0.6–6.3) | 2.1 (0.4–2.57) | 0.761 (0.571–1.014) | 0.061 |
| ATI, n(%) | 3 (6.12) | 4 (36.36) | 1.013 (0.997–1.029) | 0.012 |
OR, odds ratio; Vit-D: vitamin D; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; Hs-CRP, high-sensitivity C-reactive protein; WBC, white blood cell; RBC, red blood cell; Hb, hemoglobin; MCV, mean corpuscular volume; PLT, platelet; PA, prealbumin; ALB, albumin; AST, glutamic oxalacetic transaminase; ALT, glutamic pyruvic transaminase; ALP, alkaline phosphatase; GGT, gamma-glutamyl transpeptidase; TBil, total bilirubin; DBil, direct bilirubin; TBA, total bile acid; BUN, urea; Cr, creatinine; UA, uric acid; Cys-C: cystatin C; VB12, vitamin B12; EPO, erythropoietin; TC, cholesterol; TG, triglycerides; FBG, fasting blood glucose; ANA, antinuclear antibodies; IFX, infliximab; TC, trough concentration; ATI, anti-TNFα antibody